Biocryst Pharmaceuticals Inc Liquidation Value
BCRX
Other
Cash & Equivalents
$89.74M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $89.74M
Total Obligations: -$207.71M
$-117.97M
Per share: $-0.55
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $89.74M
AR: $106.82M
Total Obligations: -$207.71M
$-11.15M
Per share: $-0.05
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $89.74M
AR: $106.82M
Inventory: $5.40M
Total Obligations: -$207.71M
$-5.75M
Per share: $-0.03
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-117.97M | $-0.55 |
| Liquid Liquidation Value | $-11.15M | $-0.05 |
| Operating Liquidation Value | $-5.75M | $-0.03 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $89.74M |
| Accounts Receivable | $106.82M |
| Inventory | $5.40M |
| Current Liabilities | $196.07M |
| Long-term Debt | $0 |
| Op. Lease Liability | $8.89M |
| Finance Lease | $2.75M |
| Shares Outstanding | 213.1M |
Explore all 210 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $89.74M | $106.82M | $5.40M | $15.83M | $196.07M | $0 | $8.89M | $2.75M |
| 2025-09-30 | $84.08M | $91.33M | $5.23M | $5.57M | $190.24M | $194.37M | $8.77M | $3.18M |
| 2025-06-30 | $88.03M | $91.18M | $5.04M | $8.59M | $177.16M | $242.79M | $8.88M | $3.66M |
| 2025-03-31 | $105.19M | $93.39M | $6.87M | $10.05M | $139.85M | $315.41M | $8.85M | $4.11M |
▼ Community Notes